NCT00057473已完成2 期
A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
Bristol-Myers Squibb1 个研究点 分布在 1 个国家开始时间: 2003年2月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 1
- 主要终点
- estimate response rate
研究概览
简要总结
This clinical research study is being conducted to investigate the effectiveness of combining carboplatin and irinotecan, versus irinotecan alone, in treating children who have refractory solid tumors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 1 Year 至 21 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Arm A
Experimental
干预措施: carboplatin + irinotecan (Drug)
Arm B
Active Comparator
干预措施: irinotecan (Drug)
结局指标
主要结局
estimate response rate
次要结局
- evaluate safety
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung CancerSmall Cell Lung CancerNCT00695292SCRI Development Innovations, LLC37
已完成
2 期
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerLung CancerNCT00469898Vanderbilt-Ingram Cancer Center50
已完成
2 期
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCarcinoma, Small Cell LungLung CancerNCT00308529SCRI Development Innovations, LLC55
已完成
2 期
Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCarcinoma, Small Cell LungNCT00294931SCRI Development Innovations, LLC50
已完成
2 期
Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer PatientsOvarian NeoplasmsNCT01124435Catholic University of the Sacred Heart45